Skip to main content

Politicians make promises on their stump — we watch and hold them accountable.

Help keep the record honest →Create an account
PartialHealth care / prescription drug prices

Newsom pledged that through the state's CalRx program, California would make insulin available at about $30 for a 10mL vial (and $55 for a five-pack of pens), a roughly 90% cut from typical prices.

Sources (click to view full provenance)

Propose an edit to this promise's details

Suggest a sourced correction to the promise text, topic, scope, significance, or dates. Changing the promise text requires a source. Your suggestion is reviewed before it changes the record.

Sign in and complete the Contributor Agreement to propose an edit.

Assessments

evidence-backed verdicts

These are sourced verdicts from fact-checkers or community evidence reviews — not opinions.

PartialFact-checker reviewConfidence: 88%

The pledge (2023-03-18) had two concrete CalRx deliverables, promised for 2024: insulin at ~$30 for a 10mL vial AND $55 for a five-pack of pens. All three cited sources are reachable and their quotes are genuine (verified via WebFetch). Source 1 (calrx.ca.gov, PRIMARY) confirms the $55 five-pack of pens is "now available" while the $30 vial is still "engaging with the FDA while conducting essential quality testing" — it independently confirms both the $55 pen delivery and the $30 vial target. Source 2 (chhs.ca.gov, PRIMARY) confirms the pen launch (Jan 1 2026, $45 to pharmacies / $55 per five-pack of 3mL pens, $11/pen). Source 3 (calmatters.org, REPUTABLE_SECONDARY) confirms the delay: the Landsberg "I wish I could sit here today and say we have a date certain" quote is verbatim, the ADA impact statement is present, and it confirms the two-part price ($30 vial / $55 pen) and the missed 2024 date ("more than a year behind schedule"). So exactly one of two deliverables (the $55 pen) has materialized while the headline $30 10mL vial remains undelivered with no date certain. That is genuine partial fulfillment. The rating correctly declines FULL/CHAMPIONED despite Newsom's clear ownership of CalRx, because a core promised component is still missing and the effort ran years behind. PARTIAL is well-supported and does not overstate the evidence.

Your opinion on this assessment(clearly labeled opinion)

Sign in to vote.

Discussion

community opinions

Comments are user opinions — not verdicts. They do not affect the official assessment.

Sign in to join the discussion.

Propose a correction

community accountability

See an error in the promise text, status, significance, or missing source? Submit a sourced correction — a reviewer will evaluate and apply it if accurate. Your submission must cite evidence; unsourced changes are not accepted.

Sign in or create an account to propose a correction.

Debate

sourced community arguments

These are sourced community arguments — not StumpWatch assessments. Each cites a source and is community-contributed; it does not change the official status or rating above.

No arguments yet

Be the first to weigh in. Every argument cites a source and is reviewed before it publishes. Create an account to add one and help keep this promise honest.

Add a sourced argument

Cite a source for your point. Submissions are held for reviewer approval before they appear.

Sign in or create an account to add an argument.

StumpWatch is live, and the record is still growing. Many promises and positions aren’t tracked yet, and some features are still in beta. Add a sourced promise and help keep the record honest.

Help keep the record honest →